OncoMethylome Sciences SA, a molecular diagnostics company with activities in Belgium, the Netherlands, and the USA, announces today the details of its capital increase and listing on the Eurolist by Euronext Brussels and Euronext Amsterdam. Following the subscription to the offered shares, OncoMethylome Sciences will issue 2,933,334 new shares for a total amount of EUR22 million at a price of EUR7.50 per share. In the event that the 15% over-allotment option is exercised in full, a total amount of EUR25 million will be raised in the offering.
